Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06381921 · ClinicalTrials.gov registry record · NA

Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain

A NA study of Abdominal Pain, sponsored by University of Connecticut.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT06381921 is a NA study of Abdominal Pain that is actively recruiting participants, run by University of Connecticut. The registered enrollment target is 120 participants, below the 144-participant average among 19 other Abdominal Pain trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06381921, a NA study of Abdominal Pain, is actively recruiting participants, sponsored by University of Connecticut.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The objectives of the study are to 1) Conduct telemetric biosignals (EDA, ECG, and EMG) recording in healthy controls and IBS participants experiencing cutaneous and visceral pain; and 2) Validate the OIME index as a biomarker for quantifying pain in IBS participants and its capability to assess the treatment of IBS pain via an ambulatory trial.

Conditions Studied

Interventions

  • BEHAVIORAL IBS-PPSM intervention

Study Locations (1)

Connecticut

  • Vernon Cottage, Depot Campus - Storrs

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-09-08
Est. Completion 2029-02-28
Phase NA

Sponsor

University of Connecticut

107 total trials

What the Registry Record Tells You About NCT06381921

The ClinicalTrials.gov registry entry for NCT06381921 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 144-participant average among 19 other Abdominal Pain trials with a reported enrollment target (17% lower). The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Abdominal Pain appearing as the primary indexed condition, and to 1 intervention - of which IBS-PPSM intervention is the first listed.

NCT06381921 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT06381921 about?

NCT06381921 is a clinical study titled "Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain". The objectives of the study are to 1) Conduct telemetric biosignals (EDA, ECG, and EMG) recording in healthy controls and IBS participants experiencing cutaneous and visceral pain; and 2) Validate the OIME index as a biomarker for quantifying pain in IBS participants and its capability to assess the...

What is the current status of trial NCT06381921?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-09-08. Estimated completion is 2029-02-28.

What conditions does trial NCT06381921 study?

This clinical trial studies the following conditions: Abdominal Pain.

What interventions are being tested in trial NCT06381921?

The interventions under investigation include: IBS-PPSM intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06381921?

This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06381921 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abdominal Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.